Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy.
Li ZC, Wang J, Liu HB, Zheng YM, Huang JH, Cai JB, Zhang L, Liu X, Du L, Yang XT, Chai XQ, Jiang YH, Ren ZG, Zhou J, Fan J, Yu DC, Sun HC, Huang C, Liu F.
Li ZC, et al. Among authors: du l.
Cell Rep. 2024 Mar 26;43(3):113877. doi: 10.1016/j.celrep.2024.113877. Epub 2024 Feb 27.
Cell Rep. 2024.
PMID: 38421869
Free article.